title: Management cost of acute limb ischaemia.
abstract: The cost of attempting limb salvage in patients who presented with acute lower limb ischaemia was recorded prospectively for 20 months. Seventy-five patients were admitted during the study; 45 were treated primarily by radiological intervention and 18 had primary surgery. The remainder were treated conservatively. Patients who had primary surgery required fewer visits to the operating theatre than those who had primary thrombolysis, but there was no difference in the total time that the theatre or radiology suite was occupied: median 2.3 (10th centile range 1.5-5.0) h and 3.0 (2.0-5.0) h respectively. Median (range) cost of disposables for performing surgery was Pounds 82 (58-169) and for thrombolysis was Pounds 407 (252-596). When the costs of using the theatre or radiology suite were included, the costs of both treatments were similar: surgery Pounds 683 (309-1438) and lysis Pounds 861 (611-1244). Median (10th centile range) inpatient stay for surgical patients was 9 (3-18) days and for those having thrombolysis 11 (2-29) days. Median (10th centile range) costs for bed occupancy were similar in both groups: surgery Pounds 2497 (643-9115) and lysis Pounds 2189 (902-6020). Mean cost for attempting limb salvage by surgery was Pounds 3429 (1094-10065) compared with Pounds 3230 (1543-8353) for thrombolysis.
authors.affiliation: Department of Surgery, Gloucestershire Royal Hospital, UK.
authors.forename: B D
authors.initials: BD
authors.lastname: Braithwaite
authors.forename: L
authors.initials: L
authors.lastname: Jones
authors.forename: B P
authors.initials: BP
authors.lastname: Heather
authors.forename: P A
authors.initials: PA
authors.lastname: Birch
authors.forename: J J
authors.initials: JJ
authors.lastname: Earnshaw
mesh_terms: D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D017048:Health Care Costs; D006801:Humans; D007511:Ischemia / Q000188:drug therapy / Q000191:economics / Q000601:surgery; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D010960:Plasminogen Activators / Q000191:economics / Q000627:therapeutic use*; D011446:Prospective Studies; D015912:Thrombolytic Therapy / Q000191:economics; D010959:Tissue Plasminogen Activator / Q000191:economics / Q000627:therapeutic use*
chemical_list: D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator